Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enovix Corporation filings document the regulatory disclosures of an advanced lithium-ion battery manufacturer commercializing silicon-anode battery architectures. Recent Form 8-K reports cover operating results, Regulation FD updates, customer qualification and commercial updates, executive changes, manufacturing-scale communications and board-authorized capital actions.
The filing record also includes capital-structure disclosures related to convertible senior notes, warrants to purchase common stock, share repurchase plans and common-stock matters. Proxy materials document board elections, executive compensation, equity awards and shareholder voting items, while current reports provide formal exhibits for press releases and material agreements.
Talluri Rajendra K reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp President and CEO Rajendra K. Talluri reported awards of common stock tied to performance-based restricted stock units. On February 18, 2026, 168,813 PRSUs vested after meeting performance criteria; 50% will be released on April 1, 2027 and 50% on April 1, 2028.
On the same date, 90,798 additional PRSUs vested, with 50% scheduled for release on April 8, 2027 and the remainder on April 8, 2028. Reported direct holdings include shares plus 1,446,958 shares issuable upon vesting and settlement of RSUs and vested PRSUs, including 47,775 PRSUs to be released on March 2, 2027.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding share disposition. On March 2, 2026, 1,260 shares of common stock were withheld at $5.45 per share to satisfy tax obligations tied to vested performance restricted stock units.
After this transaction, she directly owns 190,289 shares, including 137,235 shares issuable upon vesting and settlement of restricted stock units and 2,489 vested performance RSUs scheduled for release on March 2, 2027.
Enovix President and CEO Rajendra K. Talluri reported a tax-related share disposition on common stock. On March 2, 2026, 24,175 shares were withheld at $5.45 per share to satisfy tax obligations tied to vested performance RSUs. After this, he held 2,178,612 shares, including 1,446,958 issuable from RSUs and 47,775 vested PRSUs scheduled for release on March 2, 2027.
Enovix Corp Chief Legal Officer reports tax-related share withholding. Arthi Chakravarthy disposed of 5,259 shares of Enovix common stock on March 2, 2026 at $5.45 per share to cover tax withholding obligations tied to vested performance restricted stock units. After this tax-withholding disposition, direct holdings total 399,597 shares, which include 262,360 shares issuable upon vesting and settlement of restricted stock units and 10,393 vested performance RSUs scheduled for release on March 2, 2027.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a tax-withholding disposition of 2,221 shares of common stock on February 24, 2026, at $6.11 per share, to cover taxes on vested RSUs. Following this, she holds 404,856 shares, including unvested RSUs and performance RSUs with future release dates.
Enovix Corporation filed Amendment No. 1 to its Annual Report for the year ended December 28, 2025 to replace the consent of Deloitte & Touche LLP. The new consent now includes references to Enovix’s effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260).
The amendment also files updated certifications from the principal executive officer and principal financial officer under Rules 13a-14(a) and 15d-14(a. It does not modify any financial statements or other disclosures in the original report and does not reflect events occurring after the original filing.
Enovix Corporation is a global battery company focused on designing, developing, manufacturing and commercializing advanced lithium-ion batteries using a proprietary 100% active silicon-anode architecture. Its AI-1™ platform targets smartphones, smart eyewear, defense, industrial and emerging edge-AI devices that require higher energy density in tight spaces.
The company has shifted from a broad, standard-cell strategy to deeper vertical programs with a smaller set of large OEM and ODM customers. Manufacturing has been consolidated into Fab2 in Malaysia and facilities in South Korea, supported by R&D centers in India and the U.S. A recent independent test showed the AI-1™ smartphone battery reached 935 Wh/L volumetric energy density.
Enovix highlights substantial risks: scaling a new and complex manufacturing process, achieving targeted throughput and yields, controlling raw material and production costs, and maintaining key third‑party manufacturing and supply relationships. It also notes a history of losses, a need for additional capital, customer concentration in certain sectors, global trade and geopolitical exposure, and the possibility that products under development may not reach commercial scale or expected performance.
Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to $31.8 million from $23.1 million, a 38% increase, while GAAP gross margin improved to 19.2% from negative levels in 2024. Fourth quarter 2025 revenue reached $11.3 million, up from $9.7 million, with GAAP gross margin of 22.1%.
The company still posted a 2025 GAAP net loss of $156.7 million, though this narrowed from $222.2 million in 2024, and free cash flow improved to an outflow of $113.5 million from $184.8 million. Year-end cash, cash equivalents and marketable securities totaled about $621 million. Enovix’s board authorized an additional share repurchase program of up to $75 million, alongside remaining capacity of about $1.6 million under a prior plan. For first quarter 2026, the company forecasts revenue of $6.5–7.5 million and non-GAAP net loss per share of $0.14–0.18.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to restricted stock units (RSUs). On February 18, 2026, 17,650 shares of common stock were withheld at $5.95 per share to satisfy RSU tax obligations, rather than sold in the open market.
After this withholding, Talluri directly owned 2,202,787 shares, which include 1,494,734 shares issuable upon settlement of RSUs and 95,551 vested performance RSUs (PRSUs). For the PRSUs, 50% are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, each representing one share upon settlement.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding disposition of 1,116 shares of common stock at $5.92 per share tied to RSU vesting. After this transaction, she holds 191,549 shares, including 139,724 RSUs and 4,978 vested PRSUs with future release dates.